跳至主要内容
临床试验/NL-OMON27626
NL-OMON27626暂停不适用

Recurrent differentiated thyroid cancer: Towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET).

The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
100

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with a history of differentiated thyroid cancer;
  • 2. After complete thyroidectomy and ablation of functional remnants with 131I;

排除标准

  • 1. Age < 18 years;
  • 2. Pregnancy;

研究者

发起方
The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital

相似试验